เอกสารอ้างอิงมะเร็งต่อมลูกหมาก

	เอกสารอ้างอิง (มะเร็งต่อมลูกหมาก)

1.	Hennekens CH, Buring JE. Epidemiology in medicine. Boston: Little, Brown, 1987.
33.	Wingo PAC, Tong T, Bolden S. Cancer statistics 1995. CA-A Cancer J Clin 1995;45:8.
34.	Woolf SH. Public health perspective: the health policy implications of screening for prostate cancer. J Urol 1994;152:1685.
35.	Waterbor JW, Bueschen AJ. Prostate cancer screening (United States). Cancer Causes Control 1995;6:267.
36.	Walther PJ. Prostate cancer screening: why the controversy? Adv Urol Oncol 1995;4:315.
37.	Jenson CB, Shahon DB, Wangensteen OH. Evaluation of annual examinations in the detection of cancer. JAMA 1960;174:91.
38.	Gillbertsen VA. Cancer of the prostate gland. JAMA 1971;215:81.
39.	Chodak GW, Schoenberg HW. Early detection of prostate cancer by routine screening. JAMA 1984;252:3261.
40.	Thompson IM, Ernst JJ, Gangai MP, Spence CR. Adenocarcinoma of the prostate: results of routine urological screening. J Urol 1984;132:690.
41.	Lee R, Littrup PJ, Torp-Pedersen ST, Mettlin C, McHugh TA, Gray JM, Kumasaka GH, McLeary RD. Prostate cancer: comparison of transrectal US and digital rectal examination for screening. Radiology 1988;168:389.
42.	Lange PH, Ercole CJ, Lightner DJ, et al. The value of serum prostatic specific antigen determinations before and after radical prostatectomy. J Urol 1989;141:873.
43.	Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, Petros JA, Andriole GL. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991;324:1156.
44.	Rifkin MD. Ultrasound of the prostate. New York: Raven Press, 1988 .
45.	Carter HB, Hamper UM, Sheth S, Sanders RC, Epstein JI, Walsh PC. Evaluation of transrectal ultrasound in the early detection of prostate cancer. J Urol 1989;142:1008.
46.	Cupp MR, Oesterling JE. Prostate-specific antigen, digital rectal examination, and transrectal ultrasonography: their roles in diagnosing early prostate cancer. Mayo Clin Proc 1993;68:297.
47.	Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987;317:909.
48.	Cooner WH, Mosley BR, Rutherford CL, Beard JH, Pond HS, Terry WJ, Igel TC, Kidd DD. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol 1990;143:1146.
49.	Gerber GS, Thompson IM, Thisted R, Chodak GW. Disease-specific survival following routine prostate cancer screening by digital rectal examination. JAMA 1993;269:61.
51.	Mettlin C, Jones G, Averette H, Gusberg H, Murphy GP. Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers. CA 1993;43:42.
52.	Litwin MS, deKerion JB. Perspectives on the problem of prostate cancer. (Editorial) J Urol 1994;152:1680.
53.	Littrup PJ, Goodman AC, Mettlin CJ, Murphy GP. The American investigators of the American Cancer Society-National Prostate Cancer Detection Project. Cost analyses of prostate cancer screening: frameworks for discussion. J Urol 1994;1873.